Birt -Hogg -Dubé syndrome (BHD) is a human cancer disorder caused by mutations in the tumor suppressor gene Folliculin (FLCN) with unknown biological functions. Here, we show that the Drosophila homolog of FLCN, dFLCN (a.k.a. dBHD) localizes to the nucleolus and physically interacts with the 19S proteasomal ATPase, Rpt4, a nucleolar resident and known regulator of rRNA transcription. Downregulation of dFLCN resulted in an increase in nucleolar volume and upregulation of rRNA synthesis, whereas dFLCN overexpression reduced rRNA transcription and counteracted the effects of Rpt4 on rRNA production by preventing the association of Rpt4 with the rDNA locus. We further show that human FLCN exhibited evolutionarily conserved function and that Rpt4 knockdown inhibits the growth of FLCN-deficient human renal cancer cells in mouse xenografts. Our study suggests that FLCN functions as a tumor suppressor by negatively regulating rRNA synthesis.
INTRODUCTION
Birt -Hogg -Dubé syndrome (BHD) is an autosomally dominant human cancer disorder that predisposes patients to the development of benign fibrofolliculomas (neoplasms of the hair follicle), lung cysts that may cause pneumothorax and various subtypes of renal carcinoma (1, 2) . The disease is associated with germline frameshift and nonsense mutations in the Folliculin (FLCN; a.k.a BHD) gene that comprises 14 exons (3 -5) and is predicted to encode a 579 amino acid protein, FLCN (5) . Although it displays no significant homology to any known human proteins, FLCN is widely conserved across species, suggesting a crucial biological function (6) . In normal human tissues, FLCN mRNA expression was observed in various organs and cell types, including the stromal cells and type 1 pneumocytes of the lung, the distal nephron of the kidney, the macrophages and lymphocytes in the tonsils and spleen and the skin and its appendages (7) . Renal tumors from BHD patients, however, showed reduced expression of FLCN (7), consistent with reports of somatic inactivation of the wild-type FLCN allele or loss-of-heterozygosity that occurs at a high frequency in BHD syndrome patients, suggesting that FLCN functions as a tumor suppressor (6) .
Recently, several genetic and biochemical studies have attempted to understand the molecular function of FLCN. In vitro studies in mammalian cell culture have demonstrated an interaction between FLCN and adenosine monophosphate-activated protein kinase (5'AMPK), mediated by two novel proteins, FLCN-interacting protein-1 and-2 (FNIP1 and FNIP2) (8 -10) . Because AMPK is a negative regulator of the mammalian target of rapamycin (mTOR) and a key energy-sensing molecule in the cell (11 -14) , the interaction between FLCN with FNIP1/2 and AMPK is indicative of FLCN's role in nutrient/energy sensing through the AMPK/ mTOR signal transduction pathways. However, some other studies have reported opposing effects of FLCN's downregulation on phosphorylated ribosomal protein S6 (p-S6) signaling cascade (15) . Induction of siRNA in human cell lines resulting in transient downregulation of FLCN produced a reduction in p-S6 (10, 15) . Renal cysts in mice heterozygous for FLCN also showed reduced p-S6 (15) . In contrast, generation of kidneyspecific homozygous knockout of FLCN mice, however, led to the development of polycystic kidneys and increased p-S6 (16, 17) . On the other hand, deletion of the yeast homolog of FLCN in Schizosaccharomyces pombe demonstrated that FLCN, believed to act in parallel with AMPK, had a completely opposite biochemical function to the AMPK target tuberous sclerosis complex (TSC2) in amino acid homeostasis (18) . These findings were especially surprising because both BHD syndrome and TSC disorder have highly similar disease symptomatology, i.e. skin lesions, cysts of the lung and kidney and renal neoplasia. Finally, a recent genetic study has shown that Drosophila FLCN (dFLCN) plays a role in regulating male germline stem cell renewal in the fly testis and functions downstream of the JAK/STAT and Dpp signaling pathways (19) . These studies suggest complicated and cell-type-or tissue-specific functions for FLCN in different biological contexts.
The Ras oncoproteins are membrane-associated molecular switches that function to transduce extracellular signals to a variety of intracellular response mechanisms. Activating mutations in ras genes are present in 15% of all cancers and almost 30% of metastatic human cancers (20) . The Ras protooncoproteins are encoded by three genes-Ki-ras, Ha-ras and N-Ras (20) . Activation of the Ki-ras oncogene has been implicated in colorectal cancer carcinogenesis (21) . Although colorectal neoplasia was not initially reported to be part of the BHD syndrome phenotype, some recent studies suggest that FLCN inactivation may also contribute to colorectal tumorigenesis (22) . Ras effectors such as the Raf Ser/Thr protein kinases (23, 24) function as mitogen-activated protein kinases (MAPK) (MAP3K) directly activating MAPK kinases that lie upstream of the ERK group of MAPKs (25) . Interestingly, increases in Raf, MEK and ERK activities have been observed in cell lines deficient in FLCN (16) . In addition, FLCN and TSC disorders share similar skin lesion symptoms. These observations raise the possibility that FLCN may interact with the Ras/Raf signal transduction pathway in causing human diseases.
Changes in cell growth and proliferation depend heavily on the rapid and efficient transcription of rRNA genes (rDNA) in the nucleolus by RNA polymerase I (Pol I) and associated transcription factors (26) . Recent studies have provided compelling biochemical evidence indicating that numerous tumor suppressors and proto-oncogenes can regulate rRNA synthesis, the first and rate-limiting step in ribosome biogenesis (27) . Because the misexpression and deregulation of components of the protein synthesis machinery in cancer cells have been extensively documented (28) , together with the knowledge that ribosome biogenesis is tightly coupled to proper cell-cycle progression (29, 30) , it is now becoming evident that disruption of key steps in the process of ribosome production can contribute to cellular transformation.
To understand the molecular function of FLCN, we studied its Drosophila homolog dFLCN (19) . We found that dFLCN genetically interacts with oncogenic Ras using the Drosophila eye system. Furthermore, we identified Rpt4 as a novel interactor of dFLCN. Recent studies have established that Rpt4 is present at the rDNA promoter and coding regions and plays an essential role in rRNA gene transcription (31) . Here, we examine the consequences of FLCN overexpression or knockdown on pre-rRNA synthesis and ribosome production and find that FLCN controls rRNA synthesis by modulating Rpt4 binding to the rDNA locus. Finally, we characterize the interaction between FLCN and Rpt4 in an in vitro mammalian system using a cell line (UOK-257) derived from the kidney tumor of a 46-year-old BHD patient. We demonstrate that knocking down Rpt4 in these cells inhibits tumor growth in a mouse xenograft model. Our results suggest that the tumor suppressor FLCN might normally limit rRNA synthesis by antagonizing Rpt4 function.
RESULTS

FLCN is involved in Ras
V12 -induced oncogenic growth
In the process of studying tumorigenesis caused by oncogenic Ras in Drosophila, we identified the fly homolog of human FLCN, a tumor suppressor gene mutated in renal carcinoma.
In this study, we utilized a constitutively active form of the Drosophila Ras1 gene (Ras V12 ). Ras1 regulates cell growth and cell proliferation by modulating the MAPK signaling cascade during eye development (32, 33) . Expression of Ras1 V12 with an eye-specific driver eyeless-Gal4 during Drosophila imaginal disk development induces cellular overproliferation and hyperplastic growth of the eye and causes lethality (34, 35) . Utilizing a set of chromosomal deficiency lines (FlyBase), we sought to identify genes that in half dose would enhance or suppress the Ras1 V12 -induced eye phenotype (see Materials and Methods). A chromosomal deficiency, Df(3L)Exel6111, that deletes dFLCN; a.k.a. BHD dominantly enhanced Ras-induced tumorigenic phenotypes (Supplementary Material, Table S1 ). We found that expressing dFLCNRNAi enhanced and overexpressing dFLCN suppressed the Ras1 V12 -induced eye overgrowth phenotype.
Identification of a novel FLCN-interacting partner, Rpt4
Although widely conserved among species, FLCN does not contain any known functional domains (5), and thus its molecular function has remained unclear. Other than a chromosomal deficiency, which deletes dFLCN and a few other genes (FlyBase), and the RNAi lines, mutations in Drosophila dFLCN are not available. To understand FLCN's molecular role, we sought to identify its interacting partners. To this end, we used the full-length dFLCN as a bait to isolate binding partners expressed from a Drosophila cDNA library using the Cytotrap TM Yeast Two-Hybrid System (36, 37) . This system detects protein -protein interactions that occur in the cytoplasm (Fig. 1A) , significantly reducing the number of false positives associated with the conventional yeast 2-hybrid assays that rely on nuclear interaction ((38); see Materials and Methods). This screen identified four putative interactors of dFLCN, one of which was the 26S proteosome component and ATPase, Rpt4 ( Fig. 1B ; Supplementary Material, Table S2 ).
We confirmed the physical interaction between dFLCN and Rpt4 by coimmunoprecipitation experiments using protein extracts from HEK-293T cells cotransfected with Rpt4-Flag and dFLCN-HA. Using an anti-HA antibody to immunoprecipitate dFLCN-HA-associated proteins, we detected Rpt4-Flag
in the immunocomplex (Fig. 1C) . Moreover, we immunostained Drosophila Schneider (S2) cells expressing transgenes and observed that Rpt4-Flag and dFLCN-HA were colocalized in the nucleus ( Fig. 1D; Supplementary Material, Fig. S1A ).
Collectively, these findings demonstrate that dFLCN and Rpt4 interact and physically associate with each other. The tubulin80-Gal4 driver was utilized to induce dFLCN-RNAi in two independent lines and a white-RNAi (targeting the white gene) as control RNAi. The w 1118 strain was used as wild-type control. Salivary glands from these animals were immunostained using anti-Fibrillarin and were visualized using confocal microscopy. Representative images are shown. Note that tissue sections from dFLCN-RNAi larvae showed a multilobed nucleolus (middle) when compared with wild-type control (left), and that this phenotype was neutralized when dFLCN was overexpressed (right). (G) Repression of dFLCN produces an increase in nucleolar volume. Induction of dFLCN-RNAi in salivary gland cells resulted in increased nucleolar volume when compared with wild-type and dFLCN-HA cells. An average of 10 cells in 5 different salivary glands were counted for each genotype. Average nucleolar volume was calculated by taking the ratio of the area stained with fibrillarin, to the total nuclear area. Student's t-test was used to calculate P-values when compared with wild-type control (w
1118
). dFLCNi-1 and dFLCNi-2 denote two independent RNAi lines. Significant values are indicated by P-values.
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Human Molecular Genetics, 2013, Vol. 22, No. 2 Rpt4 expression directly affects rRNA synthesis. Total RNA was isolated from equal number of third-instar larvae of wild type, Rpt4 +/ -and UAS-Rpt4/+ genotypes. QPCR, using primers spanning the 5'ETS of the Drosophila rDNA locus, was used to measure pre-rRNA synthesis. Pre-rRNA levels were decreased in Rpt4 +/ -flies, whereas flies overexpressing Rpt4 animals had 3-fold higher levels of pre-rRNA when compared with wild-type flies. (C) Reduced dFLCN expression promotes rRNA synthesis. dFLCN-RNAi and dFLCN-HA expression were driven using the tubulin80-Gal4 promoter. Total RNA was isolated from equal number of third-instar larvae of wild type, dFLCN-RNAi (1 & 2) and dFLCN-HA genotypes. Pre-rRNA levels were 4-7-fold higher in both dFLCN-RNAi strains when compared with wild type, whereas dFLCN-HA overexpression produced no significant change in the amount of pre-rRNA. (D) Rpt4-regulated changes in rRNA synthesis result in a concomitant decrease in body size of Rpt4 S1B ). Although dFLCN has been reported to localize in the cytoplasm (8, 19) or in both nuclear and cytoplasmic compartments (9), our finding is consistent with reports of yeast Rpt4 residing almost exclusively in the nucleus, throughout the cell cycle (39) and the presence of proteasomes in the nucleolus (40, 41) . Next, we investigated the functional significance of dFLCN's localization by examining nucleolar morphology in larval salivary glands that contain large polyploid cells with easily identifiable nucleoli. In contrast to wild-type polytene cells and cells expressing control RNAi, which contained a single round nucleolus (Fig. 1F ), we observed that salivary glands from larvae expressing any of the two independent dFLCN-RNAi lines had multiple-lobed nucleoli (Fig. 1F , middle), with increased total nucleolar volume (Fig. 1G ). The efficiency of our respective RNAi fly strains was confirmed by real-time PCR (RT-PCR) and western blot analysis (Supplementary Material, Fig. S2 ). The effects of the dFLCN RNAi lines on nucleolar volume were neutralized by overexpressing dFLCN-HA ( Fig. 1F and G), suggesting that the RNAi-induced defects were not due to off-target effects.
Modulation of pre-rRNA levels and animal growth
Although Rpt4 is an essential component of the 26S proteasome responsible for protein degradation, a direct role for Rpt4 in rRNA transcription has been reported (31, 42) . And, because dFLCN localizes to the fibrillar centers-the sites of transcription and processing of rRNA (43), we next explored the possibility that dFLCN may be involved in regulating aspects of rRNA synthesis or ribosome processing.
Because Rpt4 directly regulating rRNA transcription was previously shown in mammalian cells (31), we first examined whether changes in Rpt4 expression could alter pre-rRNA levels in Drosophila as well, using quantitative RT-PCR (qPCR) with probes to the Drosophila 5' external transcribed spacer (ETS) region ( Fig. 2A) . Indeed, flies heterozygous for an Rpt4 loss-of-function allele (Rpt4 G0345 ) exhibited an almost 2-fold decrease, whereas overexpression of an Rpt4 transgene resulted in a 6-fold increase in pre-rRNA levels (Fig. 2B ). An increase in pre-rRNA levels was confirmed by in situ hybridization experiment (Supplementary Material, Fig. S3 ). These findings were consistent with results from a previous study of Rpt4, where treatment with proteasomal inhibitor MG132 suppressed pre-rRNA production in yeast, human and mouse cells and diminished Rpt4 occupancy at the rDNA promoter and coding regions in NIH3T3 cells (31) . Consistent with the changes in pre-RNA levels, flies overexpressing Rpt4 exceeded their wild-type counterparts in both body weight and wing size, whereas Rpt4 +/ -animals weighed less ( Fig. 2D ) and had smaller wings than control animals (Supplementary Material, Fig. S4A ).
To investigate if dFLCN plays a role in controlling rRNA transcription, we examined pre-rRNA synthesis in flies overexpressing dFLCN-RNAi or dFLCN-HA and compared with control flies. Ubiquitous expression of dFLCN-RNAi and dFLCN-HA using the tubulin80-Gal4 driver resulted in a 3 -5-fold increase in pre-rRNA levels in both dFLCN-RNAi lines, whereas the amount of pre-rRNA in animals overexpressing dFLCN-HA was marginally decreased when compared with wild-type flies, as measured by qPCR ( 
Overexpression of dFLCN can inhibit Rpt4 binding to the rDNA locus
It has been reported that Rpt4 specifically regulates rRNA transcription via direct binding to the rDNA promoter and coding regions and recruiting the transcription machinery (31) . Because loss of dFLCN had similar effects to Rpt4 overexpression on rRNA levels and because dFLCN and Rpt4 physically interact, we tested the possibility that dFLCN might affect pre-rRNA levels through antagonizing Rpt4 function. To test this idea, we conducted chromatin immunoprecipitation (ChIP) analysis using Drosophila S2 cells that were transfected with Rpt4-Flag, both Rpt4-Flag and dFLCN-HA, or the control vector. Because a previous study reported binding of Rpt4 to both the promoter and coding regions of the rDNA locus in NIH3T3 cells (31) without underscoring any specific binding sites, we used several primer pairs that spanned the Drosophila rDNA coding and promoter regions ( Fig. 2A) . We found that, in the presence of overexpressed dFLCN-HA, Rpt4 occupancy at the promoter and coding regions was dramatically reduced (Fig. 2F) . As a negative control, Rpt4 showed minimal binding to the rp49 promoter, and this binding was not affected by expression of dFLCN-HA and or its lack thereof (Fig. 2F) .
To investigate the effects of dFLCN expression on Rpt4-stimulated rRNA transcription, we measured pre-rRNA protein (GFP)-expressing vector, Rpt4-FLAG alone or cotransfected with both Rpt4-FLAG and dFLCN-HA plasmids. ChIP assay using a FLAG antibody demonstrates reduced Rpt4 transcript levels at the rDNA promoter and coding regions when coexpressed with dFLCN, as measured by qPCR. (G) dFLCN regulates rRNA synthesis by inhibiting Rpt4. Total RNA was isolated from S2 cells, expressing GFP or Rpt4-FLAG alone or both Rpt4-FLAG and dFLCN-HA. Pre-rRNA levels were lower in cells expressing both dFLCN and Rpt4 when compared with control cells with GFP only or Rpt4-FLAG, as measured by qPCR using primers to the Drosophila ETS region. P-values were calculated using Student's t-Test for paired samples. Fig. S5A and B) and observed relatively equal levels of both species in the doubly transfected cells, thus confirming the validity of pre-rRNA suppression that was observed on induction of dFLCN-HA. Taken together, these results suggest that dFLCN plays a role in regulating rRNA transcription by inhibiting Rpt4 association with the rDNA locus.
Ribosomal RNA synthesis is important for Ras
V12
-induced oncogenic growth
We identified dFLCN in a genetic survey of modifiers of Ras V12 -induced overproliferation phenotype (Supplementary Material, Table S1 ). To confirm the genetic interaction between dFLCN and Ras V12 , we further examined whether loss or overexpression of dFLCN could suppress or enhance Ras V12 -induced tumor phenotype. Indeed, expression of dFLCN-RNAi enhanced Ras V12 -induced tumorigenicity as manifested by the severity of hyperplasticity of the eye (Fig. 3A) and decreased fly survival rate (Fig. 3B ) in flies heterozygous for dFLCN-RNAi and Ras V12 . Conversely, the induction of dFLCN-HA expression was able to partially rescue the Ras V12 -induced overgrowth phenotype (Fig. 3A) , albeit unable to significantly promote animal survival (Fig. 3B) . These results suggest that dFLCN counteracts Ras V12 -induced hyperplastic growth, although does not mediate all the effects of Ras V12 (such as lethality). To further understand the effects of dFLCN on Ras V12 -induced overgrowth, we investigated the role of dFLCN in Ras V12 -mediated cell overproliferation in the developing eye. As demonstrated by the number of cells positively stained for the mitotic marker phospho-histone H3 (pH3) in the eye imaginal disks, Ras V12 expression drives cellular proliferation that was exacerbated by the loss of dFLCN and restored to almost wild-type levels when dFLCN was overexpressed ( Fig. 3C and D) , suggesting that dFLCN is essential for mediating cell proliferation in the context of oncogenic Ras V12 .
Because increased rRNA synthesis and ribosome biogenesis are widely recognized features of transformed cells (27, 44) , we suspected that changes in the levels of Rpt4, which is known to directly bind to the rDNA locus and regulate rRNA synthesis, could influence the Ras V12 -dependent eye phenotype. Indeed, heterozygosity of Rpt4 significantly improved the viability of flies expressing Ras V12 (Fig. 4A) . Consistent with this finding, overexpression of Rpt4, which elevates rRNA synthesis in adult flies (Fig. 2B) , adversely affected fly survival in the Ras V12 genetic background (Fig. 4A) .
To confirm that rRNA transcription is important for Ras V12 -mediated tumorigenesis, we examined a mutant allele of Rpl135 (Rpl135 k16513 ) that has reduced levels of rRNA (45) in the Ras V12 genetic background. Rpl135 encodes a large RNA Pol I subunit essential for rRNA transcription (46) . We found that heterozygosity for Rpl135 (Rpl135 k16513 /+) was able to suppress the lethality induced by oncogenic Ras V12 in the developing Drosophila eye and improve fly survival as well (Fig. 4B) . Thus, rRNA synthesis indeed affects oncogenic growth, consistent with previous findings (27, 44) .
Collectively, these results indicate that dFLCN plays a role in negatively regulating rRNA synthesis and that loss of dFLCN promotes cell growth in both normal and neoplastic tissues, likely via increasing rRNA synthesis.
Human FLCN is localized in the nucleolus and interacts with Rpt4
We next investigated whether the function of FLCN as shown in Drosophila is conserved in mammals. We first carried out immunostaining in human cells, using antibodies raised against human FLCN (see Materials and Methods; Supplementary Material, Fig. S6 ). We found that, similar to dFLCN, human FLCN is enriched in the nucleolus in HeLa cells (Fig. 5A-D) and also in normal human skin and kidney tissue samples (Fig. 5E and F' ; Supplementary Material, Fig. S7 ). To further substantiate these results, first we examined subcellular distribution of FLCN in HeLa cells by fractionation studies. We found that FLCN was indeed mainly detected in the nuclear fraction (Fig. 5G) . Further fractionation of the HeLa cell nucleus lysates showed that human FLCN was predominantly detected in the nucleolus fraction, although a small amount of FLCN was detected in the nucleoplasm (Fig. 5H) . Second, we examined FLCN and Rpt4 interaction by coimmunoprecipitation. Using anti-FLCN to immunoprecipate FLCN from HEK293T cell lysates (Fig. 5I) , V12 induced lethality. Note that dFLCN knockdown significantly worsened Ras V12 -induced lethality. Overexpression of dFLCN-HA was unable to improve the dramatic lethality caused by Ras V12 expression. * * * indicates P , 0.001 by Student's t-Test. (C and D) Eye imaginal disks from transgenic animals under the control of the eyelessGal4 driver were immunostained using pH3 antibodies and photographed with a confocal microscope. Note that induction of dFLCN-RNAi in an oncogenic Ras V12 background promoted cell proliferation resulting in massive overgrowth of the eye disk, whereas overexpression of dFLCN-HA restores mitotic cell population to almost wild-type levels, rescuing the hyperplasticity of the eye tissue. The number of pH3-positive (pH3+) cells in at least 10 imaginal eye disks was used to quantify the average number of pH3+ cells per imaginal disk for each genotype. * * * indicates P , 0.001 by Student's t-Test.
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we detected Rpt4 in the immunoprepitates, suggesting that human FLCN and Rpt4 occur in a complex in cell culture. These results suggest that FLCN and Rpt4 interaction may be evolutionarily conserved between flies and humans.
Reexpressing FLCN in BHD patient-derived UOK-257 cells reduces rRNA synthesis
To determine if FLCN-dependent regulation of rRNA synthesis is also conserved in mammalian cells, we examined a cell line (UOK-257) derived from the renal tumors of a BHD patient who is deficient in FLCN expression (47) . We infected UOK-257 with a human FLCN-expressing lentiviral vector to create an FLCN-supplemented cell line (UOK-257-FLCN) (Fig. 6B ) and measured levels of pre-rRNA in both the FLCN-null (UOK-257) and FLCN-expressing cells (Fig. 6C ). We observed a 2-fold decrease in pre-rRNA levels in FLCN-expressing cells when compared with FLCN-deficient (UOK-257) and mock infected cells (UOK-257-empty) (Fig. 6C) . We also compared the ribosome distribution profiles of these particular cell lines and found that consistent with our measurement of pre-rRNA levels, FLCN-deficient cells had significantly higher amounts of the 40S, 60S ribosomal precursor subunits and greater levels of mature 80S ribosome when compared with the FLCN-supplemented and mock infected cells (Fig. 6D -G) . Normal levels of the immature and mature ribosomal subunits in HEK-293T cells ( (48) . On the whole, these results indicate that the mechanistic control of rRNA synthesis and ribosome production exerted by FLCN may also be conserved between flies and humans.
Knocking down Rpt4 expression in UOK-257 cells inhibits tumor growth in nude mice
Our results in flies and in cell culture systems suggest that inhibiting Rpt4 activity or its binding to the rDNA locus can suppress rRNA synthesis, which may contribute to tumor suppression. To determine whether this is also true in vivo, we established UOK-257 cell lines stably transfected with constructs expressing small hairpin RNA (shRNA) targeting Rpt4 or expressing a control shRNA (see Materials and Methods; Supplementary Material, Fig. S9 ). Interestingly, we found that knocking down Rpt4 had no effect on cell growth in vitro (Supplementary Material, Fig. S10A ) and had small effects on anchorage-independent growth, as assay by colony formation in soft agar (Supplementary Material, Fig. S10B ). We next injected UOK-257 cells expressing shRNA-Rpt4 constructs, scrambled-green fluorescent protein (GFP) vector and untransfected cells subcutaneously into flanks of 3-week-old nude/severe combined immunodeficiency mice and monitored the tumor growth for 2 -3 weeks. We , of the Drosophila Pol I complex, known to cause a marked decrease in rRNA synthesis, was crossed with recombinants expressing Ras V12 under the control of the eye-specific eyeless-Gal4 promoter. Induction of the oncogenic Ras V12 produces significant fly lethality, which is partially suppressed in the Rpl135 K16513 /+ background.
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found that downregulation of Rpt4 expression significantly inhibited tumor growth in vivo when compared with the scrambled-GFP and untransfected control (Fig. 7A -C ). Mice were sacrificed after 3 weeks, their tumors excised and subjected to RT-PCR to assess Rpt4 mRNA levels (Supplementary Material, Fig. S11 ). In the tumor cells expressing shRpt4 that did grow in mice, we detected Rpt4 mRNA expression (Supplementary Material, Fig. S11 ), suggesting that shRpt4 expression had been selected against these cells. These results indicate that downregulation of Rpt4 can effectively counteract tumor growth resulting from loss of FLCN and suggest that Rpt4 inhibition may present a novel methodology to inhibit tumor development in BHD patients.
DISCUSSION
We have identified a novel role for the tumor suppressor gene FLCN in negatively regulating rRNA synthesis by inhibiting binding of the proteasomal ATPase, Rpt4, to the ribosomal DNA locus (rDNA). Rpt4 is known to associate with components of the rRNA transcriptional machinery (31) and promote rRNA synthesis, a key step in the progression of cancer (27) . Our analysis also uncovered an interaction between FLCN and the Ras/Raf pathway. Additionally, our study demonstrated that improper regulation of rRNA gene synthesis contributes to the pathology of eye hyperplasia caused by expression of an oncogenic allele of Ras (Ras V12 ) in Drosophila. We have Western blot of subcellular fractions of HeLa cell lysates shows that human FLCN was mainly detected in the nucleus (G). Further fractionation of the HeLa cell nucleus lyates showed that FLCN was predominantly localized in the nucleolus, although a small amount of FLCN was detected in the nucleoplasm (H). (I) Immunoprecipation experiments were done with antisera against human FLCN or control IgG from HEK293T cell lysates. The immunoprecipitates were subjected to SDS-PAGE, along with cell lysates (input), followed by immunostaining with anti-Rpt4 (human). Note that Rpt4 is detected in anti-FLCN, not control, immunoprecipitates.
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Human Molecular Genetics, 2013, Vol. 22, No. 2 further examined a cell line (UOK-257) derived from the renal tumor of a BHD patient and found that these cells, indeed, exhibit increased production of rRNA and ribosomes. Thus, the function of the tumor suppressor FLCN in controlling rRNA transcription may be conserved across species. Consistent with a role of rRNA transcription in tumorigenesis, upregulation of rRNA synthesis by overexpression of Rpt4 increased Ras V12 -induced lethality, whereas reducing rRNA synthesis by heterozygosity for Rpt4 or Rpl135, encoding the large RNA Pol I subunit (46) , decreased Ras V12 -induced lethality (Fig. 4A ). In addition, regulation of rRNA gene expression is also important for organism survival and development (41) . We found that the disruption of rRNA synthesis by altering dFLCN or Rpt4 levels indeed affected animal growth ( Fig. 2D and E) . Biochemical analysis of a BHD-patient-derived cell line also revealed a defect in rRNA synthesis (Fig. 6B -H) , thus suggesting that the molecular function of FLCN in inhibiting rRNA transcription may be conserved in humans.
FLCN may have functions in addition to regulating rRNA transcription. For instance, whereas alterations in FLCN levels affected both growth and ectopia of the eye tissue ( Fig. 3A and B) , changes in Rpl135 and Rpt4 dosage affected Ras V12 -induced lethality, but not the eye phenotypes (Figs 3 HEK-293T cells also exhibited lower pre-rRNA production when compared with UOK-257 and UOK-257-Empty, suggesting that deregulation of rRNA synthesis is unique to UOK-257 cells. Total RNA was extracted from each cell line, followed by qPCR to measure pre-rRNA levels, using primers spanning the 5' ETS of the human rDNA locus, which persists in the rRNA precursor. Normalization was conducted using primers to the mRNA encoding acidic ribosomal phosphoprotein P0 (ARPP P0). (D, E, F, G and H) Sucrose sedimentation profiles of all cell lines were generated using a 10-40% gradient. Centrifugation at 31 000 rpm for 3.5 h at 48C was performed and the gradient measured at A 254 . UOK-257 and UOK-257-Empty cell lines have equal levels of the 40S, 60S and the mature 80S subunits, whereas reconstitution of FLCN in the UOK-257-FLCN cells downregulated the production of the mature and immature subunits. HEK-293T cells were used to demonstrate that elevated levels of ribosomal subunits are a feature endemic to the UOK-257 cell line, and not a general characteristic of transformed cells. (H) Individual heights of each peak corresponding to the 40S, 60S and 80S subunits were calculated and plotted as bar graph. The average height was computed from three runs. * indicates P , 0.05 by Student's t-Test for paired samples. Note that although the empty vector transfection seems to reduce the 80S peak, the difference was not statistically significant.
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; not shown). This may be because Rpl135 and Rpt4 can only modulate rRNA production, whereas FLCN influences both cell cycle and rRNA transcription, as it has previously been reported that cell lines deficient in FLCN show upregulation of checkpoint cyclins D and E (8). It is believed that the coordination of key checkpoints during cell cycle progression with proper rRNA production is crucial in neoplastic transformation, and the cooperative deregulation of both processes by FLCN could be the stimulus for cancer development. Consistent with this idea, we found significantly large populations of mitotic cells in eye imaginal disks, where dFLCN had been knocked down and the oncogenic Ras V12 allele was overexpressed ( Fig. 3D and E) . The interaction between FLCN and Ras signaling is consistent with a previous report showing an increase in Raf/MEK/Erk activation in FLCN conditional knockout mouse model (16) .
In addition to the Ras pathway, it has also been shown that FLCN interacts with the 5'AMPK-mTOR pathway, which functions in energy and nutrient sensing, and that kidneyspecific deletion of FLCN in mice led to the development of enlarged polycystic kidneys resulting in animal death from renal failure at 3 weeks of age (16) . On treatment of FLCN knockout mice with the mTOR inhibitor Rapamycin, the cystic kidney and cell overproliferation defects were partially rescued but not completely reversed, with the mice eventually dying (16) . The data provided in this paper with regard to FLCN -Rpt4 interaction do not rule out the involvement of mTOR in the defects associated with the loss of FLCN. Indeed, mTOR has been shown to regulate rRNA synthesis (49) , which could explain the elevated rRNA levels in FLCN-deficient animals. Moreover, although overexpression of FLCN effectively inhibits recruitment of Rpt4 to rDNA (Fig. 2F) , it has little effects on the steady state pre-rRNA level or body weight (Fig. 2C, E, G) , consistent with the idea that other pathways are involved in regulating rRNA synthesis. Thus, multiple pathways could contribute to renal cell overgrowth and kidney dysfunction caused by the loss of FLCN.
The emergence of Rpt4 as a novel interacting partner of FLCN might provide new opportunities for therapeutic intervention. By uncovering the connection between FLCN and the Ras/Raf signaling module, we could exploit rational drug design and cooperation to improve efficacy and specificity or to reduce the administering dosage. For example, use of Raf kinase inhibitor together with an rRNA transcription inhibitor and/or Rapamycin, mTOR inhibitor, might be a more effective treatment of FLCN-associated cancers than either drug alone. Because cellular signaling pathways have been extensively characterized in Drosophila and because many genes are conserved from flies to humans, the results of our study could offer additional targets for the treatment of neoplasias found in BHD syndrome and also provide a genetically tractable whole organismal model for searching novel drug targets.
MATERIALS AND METHODS
Drosophila stocks and genetics
UAS-dFLCN-HA and UAS-Rpt4 transgenic lines were established using P-element-mediated transformation (50), following cloning of full-length Rpt4 and haemagglutinin-tagged Genetic screening using chromosomal deficiency strains was as previously described (53, 54) with the following specifics. To identify enhancers or suppressors of Ras V12 , a recombinant chromosome ey-Gal4, UAS-Ras V12 was generated. ey-Gal4, UAS-Ras V12 /CyO virgin females were crossed with chromosomal deficiency (Df) lines, obtained from the Bloomington Drosophila Stock Center, and were kept at room temperature (21 -228C). The F1 adult flies of the genotype ey-Gal4, UAS-Ras V12 /+, Df/+ (identified by the lack of balancer chromosomes) were scored for eye morphology and were given a score corresponding to the percentage of flies with normal or nearly normal-sized eyes. Typically, about 10% of ey-Gal4, UAS-Ras V12 /+ flies exhibit normal to nearly normal eye morphology at room temperature (21 -228C), with the rest of the flies having either hyperplastic or deformed eyes, or lacking one or both eyes (see Fig. 3A ).
Two-hybrid assay
The Stratagene Cytotrap system was used for two-hybrid (Y2H) screening (38) of interacting partners for dFLCN in a Drosophila cDNA library. dFLCN was cloned into the pSOS bait plasmid (Stratagene, La Jolla, CA, USA) and in-frame insertion was confirmed by DNA sequencing. 'Bait' plasmid (hSOS-dFLCN) and 'prey' Drosophila cDNA library were cotransformed into temperature-sensitive yeast (strain cdc25H) using a modified lithium acetate transformation protocol as previously described (36, 37) . Interaction with this 'prey' library, targeted and anchored to the plasma membrane via a myristoylation moiety, recruits the dFLCN 'bait' to the plasma membrane, restoring a deficient SOS/cdc25 pathway and allowing survival of the yeast at elevated temperatures. Each identified candidate was replated for growth selection, and DNA was recovered using yeast lyticase digestion and plasmid isolation (Promega, Madison, WI, USA). Purified interactors were then rescreened in the yeast-2 hybrid assay by direct cotransformation of the isolated prey plasmid and the hSOS-dFLCN bait. All prey plasmids that passed this rigorous screening process were sequenced for identification.
Cell lines, cell culture and transfections
A human renal cell carcinoma line, UOK-257, deficient in FLCN, derived from a patient afflicted with BHD syndrome, was a generous gift from Dr L. Schmidt (47) . To generate a stable FLCN-supplemented cell line (FLCN+), UOK-257 was infected with a FLCN-expressing vector using the VirPower Lentiviral Expression System (Invitrogen, Carlsbad, CA, USA). Cells with stably integrated viral DNA were selected using puromycin and pooled. UOK-257 cells, infected with an empty viral vector, served as the control. Dr Schmidt generously provided both the FLCN-expressing and control lentiviral vectors. We developed stable Rpt4 -knockdown UOK cell lines by infecting UOK-257 cells with two different small hairpin (sh) RNA-expressing lentiviruses (Open Biosystems) according to the instructions of the manufacturer. All cell lines were maintained in DMEM, containing high glucose (4.5 g/l), supplemented with 10% heat-inactivated fetal bovine serum (Hyclone), 2.5 units/ml penicillin and 2.5 mg/ml streptomycin. Cells were incubated at 378C in a humidified atmosphere with 5% CO 2 . S2 cells (Invitrogen, Carlsbad, CA, USA) were grown in Schneider's Drosophila Medium containing 10% heat-inactivated fetal bovine serum, 50 units/ml penicillin and 50 mg/ml streptomycin, at 268C. HEK-293T cells were transfected using Lipofectamine TM 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. S2 cells were transfected with 1 -2 mg of input plasmid using the Calcium Phosphate method (55) . Expression of pUAST-dFLCN-HA and pUAST-Rpt4-FLAG was induced by pWA-Gal4 that drives Gal4 under the control of the actin5C promoter. Cells transfected with vector pUAST were used as the control.
Immunostaining and microscopy
Immunostaining of Drosophila tissues and cells is as previously described (56, 57) with the following modifications. Drosophila eye imaginal disks from third-instar larvae were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 30 min, blocked in PBS 0.3% Triton X-100, 0.3% bovine serum albumin (BSA), 1% normal goat serum for 30 min and incubated overnight in primary antibody at 48C. Tissues were washed four times in PBS 0.3% Triton X-100 and subsequently immunostained with tetramethyl rhodamine isothiocyanate (TRITC) 546-, FITC 488-or Cy5 660-conjugated (1:250; Molecular Probes) secondary antibody at 48C overnight. S2 cells cultured on 22 × 22-1 glass cover slips (Fisher Scientific) were washed twice with ice-cold PBS, 48 h post transfection, fixed in 3.7% formaldehyde, blocked in PBS 0.1% Triton X-100, 0.3% BSA and incubated with primary antibody and fluorophore-conjugated secondary antibody overnight at 48C. The following antibodies were used: rabbit antifibrillarin (diluted 1:250; Abcam), mouse phosphohistone 3 (diluted 1:250; Cell Signaling), rat anti-HA (diluted 1:250; Roche) and rabbit anti-FLAG (diluted 1:250; Rockland).
Hela cells were seeded on chamber slides coated with poly-L-lysine, were fixed in 4% paraformaldehyde and permeablized in methanol. The cells were sequentially incubated at room temperature in anti-FLCN antibody solution (1:100) for 2 h, washed and then with anti-rabbit antibody (1:200) conjugated with FITC for 1 h, followed by incubation with mouse anti-Fibrillarin antibody solution (1:500) for 2 h and then with anti-mouse antibody (1:200) conjugated with TRITC (red fluorescence) for 1 h. The slides were then counterstained with 4 ′ ,6-diamidino-2-phenylindole, dihydrochloride to show the position of the nuclei. Fluorescence microscopy was used to observe the staining. Immunostaining of human kidney and skin were done at the Pathology Lab Services at University of Rochester Medical Center. 
Chromatin immunoprecipitation
ChIP assays were done using the cross-linking immunoprecipitation protocol (X-ChIP) from Abcam. Briefly, 1 × 10 7 cells were harvested, cross-linked using formaldehyde and sonicated to shear chromatin. Approximately, 25 mg of chromatin, used for every IP sample, was precleared with protein G-Agarose beads (Roche) saturated with salmon sperm DNA and then precipitated by an anti-FLAG antibody (Rockland). Immunoprecipitated-chromatin fragments were subsequently used for qPCR using a set of primers that spanned the promoter and coding regions of the Drosophila ribosomal DNA (rDNA) locus:
Reverse transcription and qPCR
Total RNA was extracted from whole flies or infected cells using TRIzol (Invitrogen, Carlsbad, CA, USA). RNA integrity was verified by agarose gel electrophoresis and ethidium bromide staining. Then, 1.5-3 mg of RNA was used as the template to perform reverse transcription with SuperScript III first strand synthesis system (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Q PCR analysis was done using the iCycler TM Optical Module (Bio Rad). Reactions were set up in a volume of 25 ml containing 12.5 ml of 2× SYBR Green PCR Master Mix (Bio Rad), 4 ml of 10× diluted cDNA and 25 mM of primer mix. Amplification conditions consisted of a 2 min hot start at 948C, followed by 40 cycles each of 30 s at 958C, 30 s at 588C and 50 s at 728C. All quantitative PCR reactions were set up in triplicates. Data were analyzed using iCycler software (Bio Rad).
Xenograft tumor assay
The experiment was conducted as previously described (48) . Briefly, stably infected UOK-257 cells (1 × 10 6 ) were suspended in 300 ml of medium (Sigma-Alrdich) and injected subcutaneously into both flanks of nude mice. Tumor growth was measured once a week and mice health was monitored daily. Mice bearing tumors larger than 2 cm, or showing severe health problems, were sacrificed and examined. Otherwise, tumor growth was monitored for 3 weeks after injection. At the end of Week 3, the mice were sacrificed, and tissue sections excised and flash frozen in liquid nitrogen for RNA extraction. All animal work was performed in accordance with the guidelines provided by the Animal Care and Use Committee of the University of Rochester Medical Center.
Cell proliferation assay 1 × 10 4 cells of each individual cell line were seeded in 6-well plates, in triplicates, trypsinized and counted every 24 h for 6 days.
Sucrose gradient analysis of ribosomes
Sucrose sedimentation profiles were generated as described (58) . Briefly, 1 × 10 7 cells were collected in polysome extraction buffer (50 mM MOPS, pH 7.4, 15 mM MgCl2, 150 mM NaCl, 0.5% Triton X-100, 100 mg/ml Cyclohexamide, 1 mg/ ml heparin, 2 mM PMSF, 1× protease inhibitor cocktail), lyzed by freeze thawing twice in dry ice and centrifuged at 13 000 rpm for 10 min at 48C. Standardization of lysate was done by measuring A 254 and equal A 254, and then loaded onto a 10-40% sucrose gradient containing 20 mM TrisHCl pH 7.8, 10 mM MgCl 2 , 100 mM NH 4 Cl. Gradients were spun in an SW41 rotor at 31 000 rpm, for 3.5 h at 48C. The Biocomp Piston Gradient Fractionator with a BIORAD Econo UV Monitor was used to measure gradients at A 254 . Data were analyzed using the DataQ DI-158-UP data acquisition software.
In situ hybridization
Digoxigenin (DIG)-labeled RNA probe was generated according to the manufacturer's protocol (Roche Applied Science). Tissue sections or embryos were incubated for 30 min in equal parts PBST (1× PBS, 0.1% Tween 20) and fixative (5% paraformaldehyde in PEM), followed by washing with PBST and rinsing with 1:1 solution of PBST and Hybridization solution B (Hybe B, pH 6.5, 50% Deionized formamide, 5× SSC, 10 mg/ml sonicated salmon testis DNA, 20 mg/ml tRNA, 100 mg/ml heparin). Tissues and embryos were preincubated for 1 h in Hybe B at 558C, followed by overnight hybridization at 558C with DIG-labeled probe diluted in Hybe B (1:100). On the next day, excess probe was washed off using Hybe B, followed by preincubation for 1 h, washing with PBST, incubation with anti-DIG antibody (1:2000) for 2 h at R.T, washing with PBST and rinsing with staining buffer (0.1 M Tris pH 9.5, 1 M MgCl 2 , 0.1% Tween, 5 M NaCl, 1M Levamisol). Colorimetric detection was carried out by incubating tissues and embryos in staining buffer, NBT (75 mg/ml) and
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FACS analysis
BHD patient-derived kidney tumor cells, UOK-257, were compared with stably transfected FLCN-supplemented (UOK-257-FLCN), control (UOK-257-Empty) and HEK-293T cells. Approximately, 2 × 10 6 cells were collected and resuspended in chilled PBS and subjected to FACS analysis using the Accurri C6 (2 laser, 4 color) flow cytometer. The data were analyzed using FlowJo 5.4+.
Plasmids
Drosophila Rpt4 was amplified from cDNA clone (RE23388) and inserted into the vector pGEM-T, then excised and cloned into plasmid pUAST-FLAG. The correct sequence was verified by sequencing using the T7 sequencing primer and commercial service provided by GENEWIZ (South Plainfield, NJ, USa). FLCN-expressing and empty viral vectors were generous gifts from Dr Laura Schmidt (NIH, MD, USA).
Antibody production
A synthetic polypeptide, KVDSRPKEDTQKLLS, was chosen from the C-terminal region (amino acid 523-537) of the fulllength human FLCN protein (NCBI accession number: NP-659434) based on hydrophilic profiles and was used as an antigen to raise polyclonal antisera in rabbits by a commercial source (Invitrogen, Carlsbad, CA, USA). The antisera were further affinity purified using the same peptide and validated using ELISA (performed by Invitrogen, Carlsbad, CA, USA). Western blot analyses for recombinant full-length FLCN and fragments of FLCN as well as endogenous and overexpressed FLCN, and antigen absorption assay, were done to confirm the specificity of the sera (see Supplementary  Material, Fig. S6 ).
